Kratom Research Institute

Research · 2026-04-16

Ohio University Study: Standard LC-MS Tests Misidentify 7-OH in Kratom Products, Creating False Positives

Source: Journal of the American Society for Mass Spectrometry

Why it matters

Accurate testing for 7-OH in kratom products directly affects product regulation, law enforcement actions, and public health policy. If standard tests produce false positives, regulatory agencies and courts may take enforcement action against products that do not actually contain the restricted compound.

The big picture

As states and the FDA move to restrict or ban products containing 7-OH (7-hydroxymitragynine), reliable testing methods become critical. The commonly used LC-MS transition m/z 415 → 190 has been widely adopted for 7-OH identification, but this Ohio University study demonstrates it lacks the specificity needed to distinguish 7-OH from structurally similar alkaloids in complex kratom matrices. This creates a regulatory gap where analytical results could incorrectly incriminate or exonerate products, with real consequences for manufacturers, retailers, and consumers.

Key findings

What they say

The authors wrote: "If identification had relied solely on the high-resolution mass accuracy of m/z 415.2227 and/or uncharacteristic m/z 415 → 190 transition, even when retention time matched that of the authentic standard, this peak could have been misassigned as 7-OH, resulting in a false positive identification."

Bottom line

**Standard mass spectrometry tests widely used to identify 7-OH in kratom products can produce false positives — a flaw with major implications for regulation, law enforcement, and consumer safety.**